Bank Julius Baer & Co
RDY icon

Bank Julius Baer & Co’s Dr. Reddy's Laboratories RDY Stock Holding History

Bank Julius Baer & Co’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.5K Hold
5,000
– – ﹤0.01% 562
2026
Q1 		$69.2K Hold
5,000
– – ﹤0.01% 574
2025
Q4 		$70.2K Hold
5,000
– – ﹤0.01% 556
2025
Q3 		$69.9K Hold
5,000
– – ﹤0.01% 570
2025
Q2 		$75.2K Hold
5,000
– – ﹤0.01% 518
2025
Q1 		$65.9K Buy
5,000
+469
+10% +$6.47K ﹤0.01% 525
2024
Q4 		$78.9K Buy
+4,531
New +$68.1K ﹤0.01% 499

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bank Julius Baer & Co's RDY Position: Q2 2026 in Review

Bank Julius Baer & Co held its Dr. Reddy's Laboratories (RDY) position steady in Q2 2026 at 5,000 shares worth $72.5K. The position accounts for ﹤0.01% of the portfolio, ranked #562.

Bank Julius Baer & Co first reported a position in RDY in Q4 2024 and has held it in 7 quarters since. The position peaked at $78.9K in Q4 2024. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Bank Julius Baer & Co held 5,000 shares of Dr. Reddy's Laboratories worth $72.5K as of Q2 2026.
  • Bank Julius Baer & Co left its Dr. Reddy's Laboratories share count unchanged in Q2 2026.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Bank Julius Baer & Co's portfolio in Q2 2026, its #562 holding.
  • Bank Julius Baer & Co first reported a position in Dr. Reddy's Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Bank Julius Baer & Co's Dr. Reddy's Laboratories position peaked at $78.9K in Q4 2024.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Bank Julius Baer & Co's 13F filing for Q2 2026, filed 10 Aug 2026.